The pharmaceutical industry has yet to develop highly effective treatments for common chronic and neurological issues, like Alzheimer’s and cardiovascular disease. But GenAI promises to accelerate the discovery and development of breakthrough treatments. BCG’s Priya Chandran explores possible new approaches and how breakthrough drugs can be made more affordable and more available to the patients who need them.
Learn More:
Priya Chandran: https://on.bcg.com/3ZZO5ad
BCG’s Latest Thinking on the Health Care Industry: https://on.bcg.com/4kFxhxH
Biopharma Trends 2025: https://on.bcg.com/4mX6CxN